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istory taken upon the first contact between a
psychotic adolescent or young adult and a mental health
professional often reveals subtle deviations from estab-
lished norms that were present before the psychosis.The
realms of the deviations are motor,cognitive,emotional,
and behavioral during childhood;social withdrawal and
mood and personality changes during adolescence;and
attenuated psychotic symptoms several months to sev-
eral years before the first treatment contact and the
diagnosis of psychosis (Figure 1).
1-6The period immedi-
ately preceding the onset of psychosis, during which
behavior and functioning deteriorates from a stable,
“premorbid” level of functioning and behavioral
changes occur is referred to as the “prodromal”period.
However,the factors that precipitate the transition from
premorbid to prodrome or the first incidence of seeking
help and the resultant diagnosis are not necessarily dis-
tinct illness-related events or behaviors.
Factors such as the educational level of patients and
their families, socioeconomic status, and availability of
health care may all determine when the first contact
occurs.
7,8 Also, events such as the sudden unavailabil-
ity of a caregiver able to maintain a highly sympto-
matic individual in the community or any change in
the threshold of abnormal behavior tolerated by the
community can precipitate treatment contact, hospi-
talization, and diagnosis. Hence, the presence of the
premorbid manifestation, the onset of the prodrome,
the emergence of the symptoms that define an
episode of the illness, and ascertainment of the full
syndrome of illness including formal diagnosis do not
necessarily coincide and are not always clearly dis-
tinct points in time.
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The rationale for identifying markers of latent schizophrenia
is the evidence that early treatment speeds remission and
lessens long-term deterioration. Unfortunately, however,
although the childhood and adolescence of individual psy-
chotics often reveal premorbid deviations from established
norms, while epidemiological studies identify cognitive per-
formance and social adjustment as potential premorbid mark-
ers, such signs vary widely and no typical prodrome has been
identified. Illness-related events or behaviors are not the only
factors precipitating the transition from premorbid to pro-
drome: educational and socioeconomic status are also
involved. It follows that there is a controversy surrounding the
secondary prevention of schizophrenia: because of the poor
specificity of premorbid and prodromal markers, treating such
patients implies that an unacceptably high proportion of indi-
viduals who will not ultimately develop florid schizophrenia
will be exposed to the stigma of a provisional diagnosis of
severe mental illness as well as to the adverse effects of treat-
ment. Schizophrenia, therefore, is an aggravated illustration
of the dilemmas facing much preventive therapy.139
Methods employed to investigate the phenomena pre-
ceding the first contact for help and the diagnosis of
schizophrenia are the high-risk method,the birth cohort
method, and  historical prospective (or follow back)
method.
• High-risk studies that followed offspring and siblings of
individuals affected by schizophrenia into adulthood
have demonstrated that these relatives are more likely
than the general population to be affected by emo-
tional and behavioral abnormalities and abnormal psy-
chophysiological reactions. However, despite the fact
that increased risk can be demonstrated in these pop-
ulations,this strategy has not been helpful in the study
of the premorbid phase of schizophrenia, because
most of the individuals who belong to the high-risk
groups represent a small,atypical subgroup of patients
with schizophrenia.
• Follow-up studies of individuals born in a geographical-
ly defined area over a specified period of time (birth
cohort) have mostly been carried out by national health
authorities to study protective and risk factors for
healthy development and disease.Among the most pub-
licized and complete studies are two British studies:the
Medical Research Council National Survey of Devel-
opment, covering all births during the week 3 to 9
March 1946,
9 and the National Child Development
Study,covering all births during the week 3 to 9 March
1958.
10 Developmental and scholastic achievement data
collected for these cohorts were later linked to the data
in a registry containing diagnoses of individuals dis-
charged from psychiatric hospitals.An overview of these
studies indicates that, as a group, future schizophrenia
cases had delayed developmental milestones, speech
and behavioral difficulties, and IQ scores lower by two
thirds of a standard deviation compared with individu-
als who do not appear in the psychiatric registry.
Although future cases were overrepresented in the low-
est third of the IQ scores,the level of performance seen
was not necessarily even outside the average range of
IQ scores (defined as IQs between 90 and 110,which is
0.67 SD above or below the average score of 100).
• Follow-back or historical prospective studies examine the
premorbid histories of individuals who have already
been diagnosed as suffering from schizophrenia.These
can be based on the linkage of databases containing
routine psychometric tests administered by educational
or military authorities to large numbers of healthy ado-
lescents,with national psychiatric registries.
A study based on a national population of adolescents
called by the Israeli Draft Board Registry
11 revealed
that apparently healthy individuals who several years
later developed schizophrenia had lower mean group
scores than their healthy classmates by about 1 SD on
items reflecting social adjustment and IQ (Figures 2
and 3).The differences derive from a “shift to the left”
of the future patients—one that was clearly more pro-
nounced on social adjustment than on IQ (Figure 3).
Despite the consistency between these results, their
interpretation remains uncertain.The premorbid signs
of the illness are widely variable and a single “typical
prodrome”cannot be identified.Some individuals man-
ifest shyness detectable in elementary school, many
years before the manifestation of psychosis;others have
IQ scores 0.5 to 0.8 SD lower than expected (Figure 4);
and yet others manifest progressive, continuous deteri-
oration during childhood and adolescence.It is possible
that some of the variability in the quality and time of
premorbid manifestations reflect limitations of the study
design,which are often cross-sectional assessments.A true
prospective follow-up study,specifically designed to detect
signs of premorbid schizophrenia from birth through to
the age of risk, may reveal that an individual who mani-
fests mild delay in developmental milestones as a toddler,
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Figure 1. The lag-time between the first manifestation of schizophrenia
in the community and the first treatment contact. Study 1:
McGorry et al,
1 1998, Australia; Study 2: Beiser et al,
2 1993,
Canada; Study 3: Loebel et al,
3 1992, USA; Study 4: Hafner et
al,
4 1997, Germany; Study 5: Perkins et al,
5 2000, USA; Study
6: Haas and Sweeney,
6 1992, USA.
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learning difficulties in elementary school,poor peer inter-
action as a teenager,and depressed mood as an adolescent
will develop psychosis as a young adult.Alternatively, a
particular premorbid manifestation might lead to a par-
ticular subtype of schizophrenia.
From a practical point of view, it would be tempting to
utilize the occurrence of the premorbid and prodromal
manifestations of the illness to identify individuals at
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Figure 2. Distribution of IQ in patients with schizophrenia and normal
controls. 
Figure 3. Distribution of social functioning score in patients with schizo-
phrenia and normal controls.
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Figure 4. Effect size of differences in future schizophrenia patients. RPM: Raven progressive matrices; Ottis: a test of attention.
Free paperFigure 5. Time to remission according to prior duration of psychosis (Lieberman JA, personal communication).
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imminent risk of developing schizophrenia and intervene
before the onset of the first psychotic episode, in an
attempt to delay or ameliorate it.It would be reasonable
to hypothesize that any intervention that would delay or
attenuate the first psychotic episode would have a major
impact on the long-term outcome of the illness.This idea
draws support from studies indicating that patients with
shorter duration of untreated psychosis have more rapid
symptomatic remission and may incur less deterioration in
the long run (Figure 5).
12
However,the relatively low specificity of the premorbid
and prodromal markers (Table I) has given rise to con-
cerns that an excessive number of individuals might be
unnecessarily exposed to the stigma of a provisional
diagnosis of severe mental illness.
Therefore, the question of treating individuals who are
not yet floridly psychotic has stirred public and profes-
sional debate. Yet, because of the potential benefits of
secondary prevention on one hand and the risks and
ethical implications associated with it on the other, it is
essential to search for rational strategies to assess the
risk-benefit ratio. Examining such ratios in an area
where preventive measurements are already an
accepted reality would be such a strategy. For example,
despite the fact that following remission from the first
psychotic episode only 60% of the drug-free patients
Table I. Potential early markers and risks.
CPT: continued performance test.
• Family history
• Perinatal complications
• Subtle developmental delay
• Subtle deviation on psychometric performance
• Mild behavioral abnormalities
• Stress, immigration, use of drugs? 
• Depressed mood and social decline
• Attenuated or transient psychosis
• Electrophysiological and attention (CPT) markers?
• Late paternal age at gestation
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schizophrenia a realistic goal?
• Can premorbid and prodromal manifestations of schizo-
phrenia be utilized for early detection and intervention?
• Can early intervention delay the onset of the disease, ame-
liorate its manifestation, or improve the long-term outcome?
• Do the risks for false-positive identification and stigmatiza-
tion justify the potential benefits?
Rational for early detection and treatment 
• The lag-time between the first manifestation of schizo-
phrenia and the first treatment contact ranges between a
few month and a few years
• First-episode patients treated earlier rather than later had
a faster remission
• Patients whose illness started after neuroleptics were avail-
able on a large scale (1970) have a better long-term outcome
• Because schizophrenia has its onset at a critical age for
social and vocational development, any delay in onset or
amelioration of symptoms carries a large impact in outcome
Minimal requirements for early treatment 
with antipsychotic drugs
• Predictive test
– Easy applicable, reliable, specific for the illness being
treated
• Treatment
– Good risk-benefit ratio
– Minimal and reversible adverse effects
– Low cost
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Table II. Early detection and treatment of schizophrenia.
will exacerbate within the first year,100% of the patients
are routinely treated with neuroleptics. Hence, 40% of
patients will be exposed to the adverse effects of neu-
roleptics, but are unlikely to experience a worsening of
their symptoms. Similarly, seven families of schizo-
phrenic patients must go through the effort, expense,
and potential adverse effects of intensive family ther-
apy for 1 year,to prevent relapse on the part of one out
of seven recently discharged schizophrenic patients.
The dilemma of preventive treatment is not limited to
psychiatry. For instance, approximately 70 elderly
patients with moderate hypertension must be treated
with antihypertensive drugs for 5 years to save one life,
and 100 men with no evidence of coronary heart disease
must be treated with aspirin for 5 years to prevent one
heart attack.
The early detection and treatment strategy is supported
by preliminary results from a community clinic where
youths with prodromal symptoms were treated with
open-label neuroleptics plus supportive measures, or
supportive measures alone. The results indicate that
more members of the neuroleptic-treated group were
symptom-free for a longer period of time than similar
youths given only supportive therapy or those who
refused to enroll in the trial.In a different study,nonpsy-
chotic, first-degree relatives of patients complaining
mostly of cognitive deficit also were found to benefit
from neuroleptic treatment.
In summary, while there is much interest in the events
leading to the first psychotic episode and a strong appeal
for secondary prevention, the information currently
available is still tentative (Table II). In contrast, there is
much information and a few solid practical implications
regarding the first episode of psychosis.❑
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¿Se pueden utilizar los marcadores
premórbidos y prodrómicos asociados con
la psicosis para la detección precoz y la
prevención secundaria de la esquizofrenia?
El motivo principal para la identificación de mar-
cadores de la esquizofrenia latente se basa en
que el tratamiento precoz acelera la remisión y
reduce el deterioro a largo plazo. Lamentable-
mente, aunque por una parte la niñez y la ado-
lescencia de los individuos psicóticos revelan a
menudo desviaciones premórbidas de las nor-
mas establecidas y por otra, los estudios epide-
miológicos identifican el rendimiento cognitivo
y la adaptación social como potenciales marca-
dores premórbidos, tales signos varían amplia-
mente y no se ha identificado ningún pródromo
como típico. Los acontecimientos o las conductas
relacionadas con la enfermedad no son los úni-
cos factores precipitantes para la transición
desde la condición premórbida al pródromo;
también están involucrados el nivel educacional
y el nivel socioeconómico. A causa del carácter
inespecífico de los marcadores premórbidos y
prodrómicos, una intervención preventiva y sis-
temática implica tratar una proporción elevada
y inaceptable de individuos que finalmente no
desarollarán una esquizofrenia. Estos individuos
corren el riesgo del perjuicio de un diagnóstico
psiquiátrico provisionalmente severo y de los
efectos secundarios del tratamiento. La esquizo-
frenia es una ilustración de peso de los dilemas
que enfrenta la terapia preventiva.
Les marqueurs prémorbides et prodro-
miques associés à la psychose peuvent-ils
être utilisés pour la détection précoce et la
prévention secondaire de la schizophrénie ?
La recherche de marqueurs de la schizophrénie
latente se justifie par le fait que le traitement pré-
coce de cette affection accélère sa rémission tout
en réduisant la détérioration à long terme. Mal-
heureusement, alors que l’enfance et l’adoles-
cence des individus psychotiques révèlent souvent
des déviations prémorbides par rapport aux
normes établies et que les études épidémiolo-
giques identifient la performance cognitive et
l’adaptation sociale comme des marqueurs pré-
morbides possibles, de tels signes varient large-
ment sans qu'aucun prodrome typique n'ait pu
être défini. Les événements ou les comporte-
ments liés à la maladie ne sont pas les seuls fac-
teurs susceptibles de précipiter le passage du
stade prémorbide à celui de prodrome : les
niveaux éducatif et socio-économique sont éga-
lement impliqués. D'où la controverse autour du
traitement précoce de la schizophrénie : en raison
de la médiocre spécificité des marqueurs prémor-
bides et prodromiques, une approche préventive
systématique implique que l'on traiterait une pro-
portion élevée et inacceptable de sujets qui ne
développeront pas de schizophrénie déclarée et
seront exposés au préjudice lié à la formulation
d’un diagnostic provisoire de maladie psychia-
trique sévère ainsi qu'aux effets secondaires du
traitement. La schizophrénie représente ainsi une
illustration particulièrement sévère des dilemmes
rencontrés dans le cadre de nombreux traite-
ments préventifs.
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